During a Senate hearing, Secretary of Health and Human Services Robert Kennedy announced a review of mifepristone due to safety concerns reflected in an EPPC report. This report claims nearly 11% of women experience serious adverse events from the abortion pill, significantly higher than clinical studiesâ reported 0.5%. However, the report, produced by a conservative think tank, lacks peer review and has faced scrutiny over its methodology. Critics argue that some adverse events included, like ectopic pregnancies, distort the findings, prompting a call for caution and a label change for the medication.
The EPPC paper has raised alarms by stating nearly 11% of women experienced serious adverse events from mifepristone, a figure far exceeding clinical studies' findings.
Secretary Kennedy, expressing concern over mifepristone, pointed out that the alarming figures from the EPPC suggest significant changes may be required regarding its labeling.
Critics have raised concerns about the credibility of the EPPC's findings, arguing that the absence of peer review undermines the reliability of the report's conclusions.
Fact-checkers have described the EPPC paper as flawed, pointing to issues in methodology that call into question the validity of the serious adverse event claims.
Collection
[
|
...
]